Insights

Expanding Portfolio Neuraxpharm is actively expanding its portfolio through pipeline development, partnerships, and acquisitions, presenting sales opportunities within a growing range of CNS products to meet diverse patient needs.

Global Market Presence With a direct presence in over 20 European countries and partnerships in more than 40 countries worldwide, Neuraxpharm has a broad market reach, offering potential sales expansion opportunities on a global scale.

Innovative Solutions Being a leader in CNS treatment, Neuraxpharm's constant innovation in developing new products and solutions to address unmet patient needs opens doors for sales professionals to introduce cutting-edge therapeutic options to healthcare providers.

Backed by Private Equity Supported by funds advised by Permira, a global private equity firm, Neuraxpharm's strong financial backing provides stability and potential resources for growth, signaling a secure environment for sales engagement and partnership development.

Manufacturing Capabilities Neuraxpharm's in-house manufacturing of pharmaceutical products at Neuraxpharm Pharmaceuticals in Spain offers the opportunity for sales representatives to leverage a vertically integrated supply chain, ensuring quality control and potentially competitive pricing strategies.

Neuraxpharm Tech Stack

Neuraxpharm uses 8 technology products and services including jsDelivr, cdnjs, SAP, and more. Explore Neuraxpharm's tech stack below.

  • jsDelivr
    Content Delivery Network
  • cdnjs
    Content Delivery Network
  • SAP
    Customer Relationship Management
  • jQuery Migrate
    Javascript Libraries
  • HubSpot
    Marketing Automation
  • PHP
    Programming Languages
  • Nginx
    Web Servers
  • Apache
    Web Servers

Media & News

Neuraxpharm's Email Address Formats

Neuraxpharm uses at least 1 format(s):
Neuraxpharm Email FormatsExamplePercentage
FLast@neuraxpharm.comJDoe@neuraxpharm.com
85%
First@neuraxpharm.comJohn@neuraxpharm.com
13%
FirstLast@neuraxpharm.comJohnDoe@neuraxpharm.com
1%
First.Last@neuraxpharm.comJohn.Doe@neuraxpharm.com
1%

Frequently Asked Questions

Where is Neuraxpharm's headquarters located?

Minus sign iconPlus sign icon
Neuraxpharm's main headquarters is located at Avda. Barcelona, 69 Sant Joan Despí, Barcelona 08970 ES. The company has employees across 4 continents, including EuropeSouth AmericaNorth America.

What is Neuraxpharm's official website and social media links?

Minus sign iconPlus sign icon
Neuraxpharm's official website is neuraxpharm.com and has social profiles on LinkedIn.

How much revenue does Neuraxpharm generate?

Minus sign iconPlus sign icon
As of October 2024, Neuraxpharm's annual revenue reached $750M.

What is Neuraxpharm's NAICS code?

Minus sign iconPlus sign icon
Neuraxpharm's NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does Neuraxpharm have currently?

Minus sign iconPlus sign icon
As of October 2024, Neuraxpharm has approximately 1K employees across 4 continents, including EuropeSouth AmericaNorth America. Key team members include Chief Scientific Officer: F. J. S.Chief Human Resources Officer: A. F.Chief Technology Officer: B. B.. Explore Neuraxpharm's employee directory with LeadIQ.

What industry does Neuraxpharm belong to?

Minus sign iconPlus sign icon
Neuraxpharm operates in the Pharmaceutical Manufacturing industry.

What technology does Neuraxpharm use?

Minus sign iconPlus sign icon
Neuraxpharm's tech stack includes jsDelivrcdnjsSAPjQuery MigrateHubSpotPHPNginxApache.

What is Neuraxpharm's email format?

Minus sign iconPlus sign icon
Neuraxpharm's email format typically follows the pattern of . Find more Neuraxpharm email formats with LeadIQ.
Neuraxpharm

Neuraxpharm

Pharmaceutical ManufacturingBarcelona, Spain1001-5000 Employees

Neuraxpharm is a leading European specialty pharmaceutical company focused on the treatment of the central nervous system (CNS), including both psychiatric and neurological disorders. It has a unique understanding and in-depth knowledge of the CNS market built over 35 years.
 
Neuraxpharm is constantly innovating, with new products and solutions to address unmet patient needs and is expanding its portfolio through its pipeline, partnerships and acquisitions. 
 
The company has c. 1,000 employees and develops and commercializes CNS products through a direct presence in more than 20 countries in Europe, two in Latin America, and globally via partners in more than 40 countries. Neuraxpharm is backed by funds advised by the global private equity firm, Permira.
 
Neuraxpharm manufactures part of its pharmaceutical products at Neuraxpharm Pharmaceuticals (formerly Laboratorios Lesvi) in Spain.
 
To learn more about Neuraxpharm, please visit https://www.neuraxpharm.com

Section iconCompany Overview

Headquarters
Avda. Barcelona, 69 Sant Joan Despí, Barcelona 08970 ES
NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Employees
1001-5000

Section iconMedia & News

Section iconFunding & Financials

  • $100M$1B

    Neuraxpharm's revenue is in the range of $100M$1B

Section iconFunding & Financials

  • $100M$1B

    Neuraxpharm's revenue is in the range of $100M$1B

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.